2m 2m 2m 2m 2m 2m 2m
Talphera (TLPH)
NASDAQ
$1.07+$0.02 (+1.90%)
Price as of Oct 22, 2026 7:30 PM EDT- $55.5MMarket Cap
- -7.89%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Talphera (TLPH)
$1.07+$0.02 (+1.90%)
TLPH | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.05 | ||
Change | -$0.02 (-1.87%) | ||
Open | $1.08 | ||
High | $1.10 | ||
Low | $1.05 | ||
Previous Close | $1.07 | ||
Volume | 37,968 | ||
30-Day Average Volume | 121,346 | ||
1-Week Change | -1.87% | ||
1-Month Change | -10.26% | ||
1-Year Change | -7.89% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 51.9M | ||
Total Assets | $26.8M | ||
Market Cap | $55.5M | ||
Enterprise Value | $54.8M | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$4.3M | ||
Free Cash Flow | -$3.9M | ||
EBIT | -$4.3M | ||
EBITDA | -$4.3M | ||
Net Working Capital | $13.8M | ||
EPS | -$0.06 | ||
Enterprise Value/EBITDA | -13 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 4 | ||
P/E | -18 | ||
PEG | 0 | ||
Price/Free Cash Flow | -14 | ||
Price/Operating Cash Flow | -14 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue